Two analyses in Japanese patients showed that the healing rate of GERD was 20–40% higher in CYP2C19 PMs or IMs compared to EMs, and that PMs even benefit in the prevention of relapse of GERD [49–51]. The gene discussed is CYP2C19; the disease is gastroesophageal reflux disease.